dpuleo19

$AMLX, following the Bio Techs

Long
dpuleo19 Updated   
NASDAQ:AMLX   Amylyx Pharmaceuticals, Inc.
The health care industry is being leading the charge, AMLX is the proof of that. This recent IPO just broke out of a good looking cup & handle pattern. Also, IBD is giving a 99 relative strength rating.

So, I enter today with a small position. A "pilot position", as Mark Minervini would say. The market is still under pressure so I'm testing it.

As this stock is a highly volatile I'll play for a 3:1 risk/reward.

Comment:
Just put my stop loss at breakeven
Comment:
I sold my position at breakeven just be sure. The thing is that the price hasn't break support at its MAs.

I'll keep a close eye on this one for thise week's action.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.